The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients

BACKGROUND: Overexpression of excision repair cross-complementing Group 1 (ERCC-1) is related to cisplatin resistance and defective repair of radiation damage. The purpose of this study was to evaluate the clinical significance of excision (ERCC-1) expression in nasopharyngeal cancer (NPC). MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitapanarux, Imjai, Lekawanvijit, Suree, Sripan, Patumrat, Mahanupab, Pongsak, Chakrabandhu, Somvilai, Onchan, Wimrak, Sittitrai, Pichit, Boonlert, Donyarat, Klibngern, Hanpon, Samuckkeethum, Wisarut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306241/
https://www.ncbi.nlm.nih.gov/pubmed/32582340
http://dx.doi.org/10.4103/jrms.JRMS_787_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306241/
https://www.ncbi.nlm.nih.gov/pubmed/32582340
http://dx.doi.org/10.4103/jrms.JRMS_787_18

Ejemplares similares